To compare the incomparable: COVID-19 pneumonia and high-altitude disease

Giacomo Strapazzon, Matthias P. Hilty, Pierre Bouzat, Lorenza Pratali, Hermann Brugger, Simon Rauch

Source: Eur Respir J, 55 (6) 2001362; 10.1183/13993003.01362-2020
Journal Issue: June
Disease area: -

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giacomo Strapazzon, Matthias P. Hilty, Pierre Bouzat, Lorenza Pratali, Hermann Brugger, Simon Rauch. To compare the incomparable: COVID-19 pneumonia and high-altitude disease. Eur Respir J, 55 (6) 2001362; 10.1183/13993003.01362-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-altitude pulmonary hypertension: a pathophysiological entity to different diseases
Source: Eur Respir J 2003 Dec 01;22(6):1019-1025
Year: 2003



The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Late-breaking abstract: Comparison of respiratory symptoms in chronic pulmonary obstructive disease and restrictive ventilatory impairment according to disease stage: The PLATINO study in Latin America
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011


The comparisons of severity scoring systems for community acquired pneumonia patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006



GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide
Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives
Year: 2019


I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018


An outbreak of pneumococcal-chlamydial pneumonia and acute respiratory disease (ARD) among trainees
Source: Eur Respir J 2001; 18: Suppl. 33, 464s
Year: 2001

Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Potential misclassification of causes of death from COPD
Source: Eur Respir J 2006 Oct 01;28(4):781-785
Year: 2006



Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011


Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Prevalence of chronic obstructive pulmonary disease in a western Norwegian community - a comparison of spirometric disease criteria
Source: Eur Respir J 2004; 24: Suppl. 48, 358s
Year: 2004

Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006